{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-23-001648","form_type":"8-K","ticker":"PAYS","cik":"0001496443","company_name":"Paysign, Inc.","filed_at":"2023-03-22T23:59:59+00:00","discovered_at":"2026-05-14T18:03:45.253971+00:00","generated_at":"2026-06-17T21:16:20.889309+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Paysign reports FY2022 revenue $38.0M (+29% YoY), net income $1.0M; guides FY2023 revenue $44-46M","bullets":["Full-year 2022 revenue $38.0M, up 29% YoY; net income $1.0M ($0.02 diluted EPS) vs net loss of $2.7M in 2021.","Adjusted EBITDA $5.5M, up 175% from $2.0M; Q4 revenue $10.6M, up 21%; Q4 adjusted EBITDA $1.7M, up 38%.","Board authorized $5M share repurchase program; added 78 net plasma centers in 2022, ending with 444.","FY2023 guidance: revenue $44-46M, net income $2.5-3.5M ($0.05-0.06 diluted EPS), adjusted EBITDA $6.0-7.5M.","Pharma copay revenue up 145% to $1.5M; launched 10 new pharma copay programs in 2022."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-23-001648","json":"https://secwatch.observer/filing/0001683168-23-001648.json","markdown":"https://secwatch.observer/filing/0001683168-23-001648.md","text":"https://secwatch.observer/filing/0001683168-23-001648.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1496443/000168316823001648/0001683168-23-001648-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1496443/000168316823001648/paysign_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T21:16:20.889309+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"554add68331b6eb1e551b3d0637d4eb611accfbd","claim":"Paysign, Inc. reported full-year 2022 results: revenue $38.0 million, net income $1.0 million, EPS $0.02.","evidence_excerpt":"Full-year 2022 total revenues of $38.0 million, up 29% from full-year 2021 · Full-year 2022 net income of $1.0 million, or diluted earnings per share of $0.02","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1496443/000168316823001648/0001683168-23-001648-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"full-year 2022"},{"label":"Revenue","value":"$38.0 million"},{"label":"Net income","value":"$1.0 million"},{"label":"EPS","value":"$0.02"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"dcf33df0c216aed47528001052a6a251fcc606ce","claim":"Paysign, Inc. reported the fourth quarter 2022 results: revenue $10.6 million, net income $0.7 million, EPS $0.01.","evidence_excerpt":"Fourth quarter total revenues of $10.6 million, up 21% from fourth quarter 2021 · Fourth quarter net income of $0.7 million, or diluted earnings per share of $0.01","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1496443/000168316823001648/0001683168-23-001648-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the fourth quarter 2022"},{"label":"Revenue","value":"$10.6 million"},{"label":"Net income","value":"$0.7 million"},{"label":"EPS","value":"$0.01"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}